Skip to content

Effect of Cervical Occlusion During Intrauterine Insemination (IUI)

Evaluation of the Effect of Cervical Occlusion During Infertility Treatment by Intrauterine Insemination

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00951171
Enrollment
93
Registered
2009-08-04
Start date
2009-02-28
Completion date
2011-12-31
Last updated
2012-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

Study Hypothesis: There is a difference in pregnancy rates between intrauterine insemination (IUI) in cycles performed with cervical occlusion by a balloon catheter designed for sonohysterograms as compared to those performed with a standard inseminator. The investigators will compare pregnancy rates in patients undergoing routine IUI either with balloon occlusion or with standard insemination. The patients will receive the standard clinical care per the investigators' office guidelines, except they will be randomized to insemination with either of two catheters.

Detailed description

An open speculum will be used and patients will undergo insemination with their partners sperm (same quantity in both arms). If randomized to treatment arm a balloon catheter will be filled with 1cc of air prior to insemination. The speculum will be removed immediately and the catheter will be left in for 15 minutes and then removed. Pregnancy outcomes will be recorded in both groups.

Interventions

PROCEDUREIntrauterine Insemination

The intervention arm will undergo temporary (15 minutes) cervical occlusion with the eliptosphere intracervical catheter. This catheter is typically used to perform saline infusion ultrasounds to image the uterine cavity in our practice.

PROCEDUREIUI with the standard inseminator

The control arm will undergo insemination with the standard inseminator (TOmcat catheter).

Sponsors

Women and Infants Hospital of Rhode Island
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* All patients undergoing IUI for unexplained infertility in our office: Center for Reproduction and Infertility (Providence, RI)

Exclusion criteria

* Abnormal Semenalysis TMC \< 5 million * Blocked Fallopian tubes

Design outcomes

Primary

MeasureTime frameDescription
Clinical Pregnancy1 monthpositive beta HCG test

Secondary

MeasureTime frame
Live Birth9 months
Positive Pregnancy Test14 days

Countries

United States

Participant flow

Recruitment details

All patients recruited were women scheduled previously for IUI for treatment of unexplained infertility at the WIHRI office.

Pre-assignment details

2 patients in the occlusion group experienced pain and were immediately transferrred to the standard group,thereby creating an apparent discrepancy in numbers

Participants by arm

ArmCount
Cervical Occulsion
Insemination Eliptosphere catheter filled with 1cc of air for 15 minutes. H/S Eliptosphere by Copper surgical (U.S. Patent No. 5,624,399)
40
Standard IUI
Insemination with TOmcat catheter
55
Total95

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event20

Baseline characteristics

CharacteristicCervical OcculsionStandard IUITotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
40 Participants55 Participants95 Participants
Region of Enrollment
United States
40 participants55 participants95 participants
Sex: Female, Male
Female
40 Participants55 Participants95 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
2 / 400 / 55
serious
Total, serious adverse events
0 / 400 / 55

Outcome results

Primary

Clinical Pregnancy

positive beta HCG test

Time frame: 1 month

Population: All study women undergoing IUI were included

ArmMeasureValue (NUMBER)
Cervical OcculsionClinical Pregnancy1 positive pregnancy test (beta HCG)
Standard IUIClinical Pregnancy7 positive pregnancy test (beta HCG)
Secondary

Live Birth

Time frame: 9 months

Secondary

Positive Pregnancy Test

Time frame: 14 days

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026